HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Study on anti-IgA antibody in patients with IgA nephropathy.

Abstract
Serum IgG antibodies to polyclonal IgA, IgA1 and IgA2 were evaluated by enzyme-linked immunosorbent assay in 50 patients with IgA nephropathy and 30 healthy controls to elucidate the relationship between IgA and IgG in IgA nephropathy. Anti-IgA antibody was considered positive if the titer exceeded the mean value in normal controls by greater than 2 SD. In patients with IgA nephropathy, 18 cases (36%) demonstrated anti-IgA antibody, 19 cases (38%) anti-IgA1 antibody and 7 cases (14%) anti-IgA2 antibody. Western blots confirmed the existence of anti-IgA antibody in these patients. There were no significant differences in serum IgA concentration, serum creatinine concentration, degree of hematuria, amount of urinary protein, and rate of glomerular IgG deposition between the "positive" group and "negative" group. Although the mechanism of production and the role of this antibody remain unknown, it may represent one of the diverse immune abnormalities of IgA nephropathy and may be involved in the pathogenesis of IgA nephropathy.
AuthorsS Seino
JournalNihon Jinzo Gakkai shi (Nihon Jinzo Gakkai Shi) Vol. 34 Issue 4 Pg. 361-9 (Apr 1992) ISSN: 0385-2385 [Print] Japan
PMID1635281 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Anti-Idiotypic
  • Immunoglobulin A
  • Immunoglobulin G
Topics
  • Adolescent
  • Adult
  • Antibodies, Anti-Idiotypic (analysis)
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Glomerulonephritis, IGA (immunology)
  • Humans
  • Immunoglobulin A (immunology)
  • Immunoglobulin G (analysis)
  • Kidney Glomerulus (immunology)
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: